Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

BIG EYE DIAGNOSTICS INC San Diego CA 92121 USA

UEI: SLED_02571BEF720690AB

BIG EYE DIAGNOSTICS INC San Diego CA 92121 USA is a federal contractor, registered under UEI SLED_02571BEF720690AB. It has been awarded $1 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_02571BEF720690AB

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

BIG EYE DIAGNOSTICS INC is a San Diego, California-based contractor that provides services to the Department of Health and Human Services.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with BIG EYE DIAGNOSTICS INC San Diego CA 92121 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for BIG EYE DIAGNOSTICS INC San Diego CA 92121 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in BIG EYE DIAGNOSTICS INC San Diego CA 92121 USA's top NAICS codes and agencies

NAICS: 541715
New
Federal
AUTOIMMUNE DISEASES STATISTICAL & CLINICAL COORDINATING CENTER (AD-SCCC)
Solicitation # 75N93026R00009
The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) is seeking to extend the contract for the Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC). This project provides essential support for the design, development, execution, and analysis of clinical research focused on autoimmune diseases, mucosal immunology, and primary immune deficiencies. The scope of work includes supporting the Autoimmunity Centers of Excellence and Immune Tolerance Network (ACE) and investigator-initiated clinical trials (IICT). Key responsibilities encompass statistical design and analysis, protocol development, data management, clinical safety and pharmacovigilance support, and the management of biological specimen repositories and collaboration portals. The NIAID intends to negotiate a sole source modification with Rho Federal Systems Division, Inc. under FAR Part 6.302-1 and HHSAR Part 306.302-1 to avoid significant disruptions to critical services and ensure participant safety and data integrity. The proposed 18-month extension is structured as two discrete option periods: a 12-month period from February 1, 2027, through January 31, 2028, and a 6-month period through July 31, 2028. This extension maintains the existing term type/level of effort contract structure and scope to ensure continuity of operations while the agency completes a separate competition process.
National Institutes Of Health Niaid

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 541715
New
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance medical interventions for infectious diseases. The initiative is divided into three primary research areas: Research Area 001 focuses on developing vaccine candidates using needle-free delivery routes through early-phase clinical trials; Research Area 002 targets the development of safe and effective therapeutic products, such as small molecules or monoclonal antibodies, for serious infectious diseases that are refractory to current treatments; and Research Area 003 seeks innovative in vitro diagnostic technology platforms capable of rapid, automated detection and identification of priority viral pathogens, preferably with a sample-to-answer time of less than two hours. The NIAID estimates up to 16 million dollars in funding for Fiscal Year 2027, utilizing cost-reimbursement completion-type contracts with performance periods of up to five years. Proposals must be submitted electronically via the eCPS portal by December 8, 2026, at 3:00 PM Eastern Time. Awards will be based on technical merit as the paramount consideration, followed by cost realism, with a requirement that proposals be deemed technically acceptable by a peer review group. All submissions must adhere to strict formatting guidelines, including a 75-page limit for technical proposals and compliance with HHS EIT accessibility and Section 508 standards.
National Institutes Of Health Niaid

POSTED

2 days ago

DEADLINE

in 20 days
View Details